Pacira Stock Waits for June 9 Board Fight
ISS and Glass Lewis both backed Pacira BioSciences’ board slate ahead of the June 9 proxy vote, rejecting DOMA Perpetual Capital Management’s nominees. Pacira shares closed at $22.33, up 8 cents, with a market cap near $914 million. First-quarter revenue rose 5% to $177.4 million. Pacira reaffirmed its 2026 revenue guidance and 5x30 growth plan.